benzyl (2S,3R)-3-hydroxy-2-methylazetidine-1-carboxylate

Catalog No.: 
ACZCJW041
CAS No.: 
2306247-38-9
Molecular Formula: 
C12H15NO3
Molecular Weight: 
221.26
benzyl (2S,3R)-3-hydroxy-2-methylazetidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$245.00InquiryInquiry
250mg97%$327.00InquiryInquiry
500mg97%$544.00InquiryInquiry
1g97%$816.00InquiryInquiry
5g97%$2447.00InquiryInquiry
10g97%$4076.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namebenzyl (2S,3R)-3-hydroxy-2-methylazetidine-1-carboxylate
IUPAC Namebenzyl (2S,3R)-3-hydroxy-2-methylazetidine-1-carboxylate
Molecular FormulaC12H15NO3
Molecular Weight221.26
SMILESC[C@H]1[C@H](O)CN1C(=O)OCC1=CC=CC=C1
InChI KeyRRBGNZSVKCRDFF-GXSJLCMTSA-N
Synonym2306247-38-9 | benzyl (2S,3R)-3-hydroxy-2-methyl-azetidine-1-carboxylate | Benzyl (2S,3R)-3-hydroxy-2-methylazetidine-1-carboxylate | MFCD31729397 | AS-78902 | (2S,3R)-1-cbz-3-Hydroxy-2-methyl-azetidine | P19642 | Benzyl(2S,3R)-3-hydroxy-2-methylazetidine
CAS No.2306247-38-9
PubChem CID135396369

Synthetic Route by SureRoute

1. ACZCJW041 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWKHI509 route compound structure diagram
    ACWKHI5091821740-20-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZCJW041 route product structure diagram
    ACZCJW0412306247-38-9
Inquiry

2. ACZCJW041 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZCJW041 route product structure diagram
    ACZCJW0412306247-38-9
Inquiry

3. ACZCJW041 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACZCJW041 route product structure diagram
    ACZCJW0412306247-38-9
Inquiry

Comments (0)